Ads
related to: dnli stock
Search results
Wall Street Analysts See a 163.82% Upside in Denali Therapeutics Inc. (DNLI): Can the Stock Really...
Zacks via Yahoo Finance· 5 months agoThe consensus price target hints at a 163.8% upside potential for Denali Therapeutics Inc. (DNLI)....
Denali's (DNLI) Q4 Earnings Miss, Pipeline in Focus, Stock Up
Zacks via Yahoo Finance· 2 months agoDenali (DNLI) reports lower than expected fourth-quarter financial results. The stock, however,...
Denali Therapeutics Inc. (DNLI) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Zacks via Yahoo Finance· 12 months agoDenali Therapeutics Inc. (DNLI) possesses the right combination of the two key ingredients for a...
Why Denali Therapeutics (DNLI) Stock Might be a Great Pick
Zacks via Yahoo Finance· 2 weeks agoOne stock that might be an intriguing choice for investors right now is Denali Therapeutics Inc....
In the wake of Denali Therapeutics Inc.'s (NASDAQ:DNLI) latest US$402m market cap drop,...
Simply Wall St. via Yahoo Finance· 10 months agoKey Insights Given the large stake in the stock by institutions, Denali Therapeutics' stock price...
Further weakness as Denali Therapeutics (NASDAQ:DNLI) drops 7.4% this week, taking three-year losses...
Simply Wall St. via Yahoo Finance· 1 month agoDenali Therapeutics Inc. (NASDAQ:DNLI) shareholders should be happy to see the share price up 18% in...
Shareholders in Denali Therapeutics (NASDAQ:DNLI) are in the red if they invested three years ago
Simply Wall St. via Yahoo Finance· 7 months agoIn order to justify the effort of selecting individual stocks, it's worth striving to beat the...
After losing 39% in the past year, Denali Therapeutics Inc. (NASDAQ:DNLI) institutional owners must...
Simply Wall St. via Yahoo Finance· 5 months agoKey Insights Given the large stake in the stock by institutions, Denali Therapeutics' stock price...
Denali Therapeutics Inc. (DNLI) Reports Q3 Loss, Lags Revenue Estimates
Zacks via Yahoo Finance· 1 year agoDenali Therapeutics Inc. (DNLI) delivered earnings and revenue surprises of -1.20% and 64.61%,...
Is There An Opportunity With Denali Therapeutics Inc.'s (NASDAQ:DNLI) 40% Undervaluation?
Simply Wall St. via Yahoo Finance· 12 months agoKey Insights Denali Therapeutics' estimated fair value is US$43.39 based on 2 Stage Free Cash Flow...